These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 11792000)
1. Safety of blood supply for infectious diseases in Latin American countries, 1994-1997. Schmunis GA; Zicker F; Cruz JR; Cuchi P Am J Trop Med Hyg; 2001 Dec; 65(6):924-30. PubMed ID: 11792000 [TBL] [Abstract][Full Text] [Related]
2. Risk for transfusion-transmitted infectious diseases in Central and South America. Schmunis GA; Zicker F; Pinheiro F; Brandling-Bennett D Emerg Infect Dis; 1998; 4(1):5-11. PubMed ID: 9452393 [TBL] [Abstract][Full Text] [Related]
3. Safety of blood supply in the Caribbean countries: role of screening blood donors for markers of hepatitis B and C viruses. Cruz JR; Pérez-Rosales MD; Zicker F; Schmunis GA J Clin Virol; 2005 Dec; 34 Suppl 2():S75-80. PubMed ID: 16461244 [TBL] [Abstract][Full Text] [Related]
4. Prevention of transfusional Trypanosoma cruzi infection in Latin America. Schmunis GA Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():93-101. PubMed ID: 10677696 [TBL] [Abstract][Full Text] [Related]
5. Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. Soldan K; Davison K; Dow B Euro Surveill; 2005 Feb; 10(2):17-9. PubMed ID: 15735312 [TBL] [Abstract][Full Text] [Related]
6. Transfusion-transmitted infectious diseases in Argentina, 1995 through 1997. Schmuñis GA; Zicker F; Segura EL; del Pozo AE Transfusion; 2000 Sep; 40(9):1048-53. PubMed ID: 10988304 [TBL] [Abstract][Full Text] [Related]
7. The risk of transfusion-transmitted infections in sub-Saharan Africa. Jayaraman S; Chalabi Z; Perel P; Guerriero C; Roberts I Transfusion; 2010 Feb; 50(2):433-42. PubMed ID: 19843290 [TBL] [Abstract][Full Text] [Related]
8. [Risk of Chagas disease through transfusions in the Americans]. Schmuñis GA Medicina (B Aires); 1999; 59 Suppl 2():125-34. PubMed ID: 10668254 [TBL] [Abstract][Full Text] [Related]
9. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. Schreiber GB; Busch MP; Kleinman SH; Korelitz JJ N Engl J Med; 1996 Jun; 334(26):1685-90. PubMed ID: 8637512 [TBL] [Abstract][Full Text] [Related]
10. Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria. Fasola FA; Kotila TR; Akinyemi JO Intervirology; 2008; 51(6):427-31. PubMed ID: 19321928 [TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing. Offergeld R; Faensen D; Ritter S; Hamouda O Euro Surveill; 2005 Feb; 10(2):8-11. PubMed ID: 15735310 [TBL] [Abstract][Full Text] [Related]
12. Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003. Niederhauser C; Schneider P; Fopp M; Ruefer A; Lévy G Euro Surveill; 2005 Feb; 10(2):14-6. PubMed ID: 15735314 [TBL] [Abstract][Full Text] [Related]
13. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. Al Shaer L; AbdulRahman M; John TJ; AlHashimi A Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239 [TBL] [Abstract][Full Text] [Related]
14. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy. Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219 [TBL] [Abstract][Full Text] [Related]
15. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal]. Koch C; Araújo F Acta Med Port; 2013; 26(4):371-6. PubMed ID: 24016646 [TBL] [Abstract][Full Text] [Related]
16. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR; Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study. Farshadpour F; Taherkhani R; Tajbakhsh S; Gholizadeh Tangestani M; Hajiani G; Sharifi N; Taherkhani S; Nejadbolkheyr A PLoS One; 2016; 11(6):e0157615. PubMed ID: 27309959 [TBL] [Abstract][Full Text] [Related]
18. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ; Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173 [TBL] [Abstract][Full Text] [Related]
19. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474 [TBL] [Abstract][Full Text] [Related]
20. An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy. Tosti ME; Solinas S; Prati D; Salvaneschi L; Manca M; Francesconi M; Ciuffreda M; Girelli G; Mele A Br J Haematol; 2002 Apr; 117(1):215-9. PubMed ID: 11918558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]